G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Other Current Assets Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Other Current Assets
â‚ą434m
CAGR 3-Years
0%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Current Assets
â‚ą9.5B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
39%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Current Assets
â‚ą22.3B
CAGR 3-Years
6%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Other Current Assets
â‚ą5B
CAGR 3-Years
-21%
CAGR 5-Years
-10%
CAGR 10-Years
22%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Current Assets
â‚ą3B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
2%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Current Assets
â‚ą6.6B
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Other Current Assets?
Other Current Assets
434m INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Other Current Assets amounts to 434m INR.

What is Glenmark Life Sciences Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
33%

Over the last year, the Other Current Assets growth was 0%.

Back to Top